BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15107188)

  • 1. Self-reported psychopathology in polydrug users.
    Sumnall HR; Wagstaff GF; Cole JC
    J Psychopharmacol; 2004 Mar; 18(1):75-82. PubMed ID: 15107188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; LĂ©pine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of dissociative symptoms to antisocial behavior in a sample of high-school students].
    Chabrol H; Saint-Martin C; Sejourné N; Moyano O
    Encephale; 2009 Feb; 35(1):52-6. PubMed ID: 19250994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents.
    Yen CF; Hsu SY
    J Nerv Ment Dis; 2007 Oct; 195(10):866-9. PubMed ID: 18043529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament, substance use and psychopathology in a prisoner population: implications for treatment.
    Allnutt S; Wedgwood L; Wilhelm K; Butler T
    Aust N Z J Psychiatry; 2008 Nov; 42(11):969-75. PubMed ID: 18941962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
    Milani RM; Parrott AC; Turner JJ; Fox HC
    Addict Behav; 2004 Jul; 29(5):965-71. PubMed ID: 15219343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Alati R; Kinner SA; Hayatbakhsh MR; Mamun AA; Najman JM; Williams GM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):108-15. PubMed ID: 17850992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adolescents who have tried illicit drugs and experienced psychiatric symptoms seldom seek professional help. A pilot study of 18-year old high school students in an urban district].
    Gunnarsson M; Fahlke C; Balldin J
    Lakartidningen; 2004 Apr; 101(14):1280-2. PubMed ID: 15101214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric comorbidity related to alcohol use among adolescents.
    Fidalgo TM; da Silveira ED; da Silveira DX
    Am J Drug Alcohol Abuse; 2008; 34(1):83-9. PubMed ID: 18161646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.